Statistics

Total Visits

Views
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer80

Select a period of time:

Number of views in the range

Views
BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer40

Views

Views
June 20250
July 202521
August 20251
September 202511
October 20250
November 20257
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Brazil12
Turkey3
Argentina2
Canada1
Colombia1
Germany1
Ecuador1
Paraguay1
Venezuela1
 

Top cities views

Views
Dallas10
São Paulo4
Antakya1
Asunción1
Caruaru1
Charlotte1
Cranbury1
Curitiba1
Cúcuta1
Embu Guaçu1